These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5827464)

  • 41. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment.
    Hall VC; Liesegang TJ; Kostick DA; Lookingbill DP
    Arch Dermatol; 2003 Aug; 139(8):1083-4. PubMed ID: 12925404
    [No Abstract]   [Full Text] [Related]  

  • 42. [Intravitreal injections of corticoids].
    Demols P
    Bull Soc Belge Ophtalmol; 2007; (304):117-23. PubMed ID: 17718236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ocular manifestations of HIV infection.
    Jabs DA
    Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical results of the use of paramethasone (6-alpha-fluoro-16-alpha methylprednisolone-21 acetate in some diseases of the eye].
    Pruneri F; Manfredini U
    Minerva Oftalmol; 1966; 8(4):122-5. PubMed ID: 5981292
    [No Abstract]   [Full Text] [Related]  

  • 45. [Histochrome, a new antioxidant, in the treatment of ocular diseases].
    Egorov EA; Alekhina VA; Volobueva TM; Fedoreev SA; Mishchenko NP; Kol'tsova EA
    Vestn Oftalmol; 1999; 115(2):34-5. PubMed ID: 10377874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dapsone induced haemolytic anaemia in patients treated for ocular cicatricial pemphigoid.
    Wertheim MS; Males JJ; Cook SD; Tole DM
    Br J Ophthalmol; 2006 Apr; 90(4):516. PubMed ID: 16547343
    [No Abstract]   [Full Text] [Related]  

  • 47. [Basis of the treatment and prevention of ocular onchocerciasis].
    Rolland A; Thylefors B
    Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1982; (4):33-134. PubMed ID: 7188300
    [No Abstract]   [Full Text] [Related]  

  • 48. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.
    Smith JR; Levinson RD; Holland GN; Jabs DA; Robinson MR; Whitcup SM; Rosenbaum JT
    Arthritis Rheum; 2001 Jun; 45(3):252-7. PubMed ID: 11409666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
    Del Amo EM; Urtti A
    Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Corticosteroids in ophthalmology].
    Niţulescu C
    Oftalmologia; 2001; 51(1):51-61. PubMed ID: 11519336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of non infectious ocular inflammatory disease with low doses of cyclosporin A].
    Cuchacovich M; Gatica H; Verdaguer JI; Carreño MA; Villarroel F; Verdaguer J
    Rev Med Chil; 1999 Mar; 127(3):277-85. PubMed ID: 10436711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Basic ocular pharmacotherapy.
    O'Brien TP; Reynolds LA
    J Ophthalmic Nurs Technol; 1995; 14(4):160-4. PubMed ID: 7650747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside.
    Matteucci P; Carlo-Stella C; Di Nicola M; Magni M; Guidetti A; Marchesi M; Gianni AM
    Haematologica; 2006 Feb; 91(2):255-7. PubMed ID: 16461314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction of thyroid uptake by iodine absorbed with eye-drop therapy.
    Ceccarelli C; Grasso L; Martino E; Nardi M
    J Nucl Med; 1982 Apr; 23(4):364. PubMed ID: 7069502
    [No Abstract]   [Full Text] [Related]  

  • 55. Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters.
    Attar M; Shen J; Ling KH; Tang-Liu D
    Expert Opin Drug Deliv; 2005 Sep; 2(5):891-908. PubMed ID: 16296785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of the ocular anti-inflammatory activity of steroidal and nonsteroidal compounds in the rat.
    Bhattacherjee P; Williams RN; Eakins KE
    Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1143-6. PubMed ID: 6874278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Topical drugs absorption in ocular surface diseases].
    Durán de la Colina JA
    Arch Soc Esp Oftalmol; 2001 Aug; 76(8):457-8. PubMed ID: 11484138
    [No Abstract]   [Full Text] [Related]  

  • 58. Corticosteroid iontophoresis to treat carpal tunnel syndrome: a double-blind randomized controlled trial.
    Amirjani N; Ashworth NL; Watt MJ; Gordon T; Chan KM
    Muscle Nerve; 2009 May; 39(5):627-33. PubMed ID: 19347928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of a new oral analgesic, propiram fumarate, in treating postoperative ocular pain.
    Wilson RS; Landers JH
    Ann Ophthalmol; 1982 Dec; 14(12):1172-4. PubMed ID: 7165237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Soporific drugs in ophthalmology].
    Koch EJ
    Klin Monbl Augenheilkd; 1966; 148(4):528-30. PubMed ID: 5989449
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.